Z3 Capital Partners »

Trevi Therapeutics shares owned by Z3 Capital Partners

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Z3 Capital Partners from 13F filings

Historical chart of Z3 Capital Partners investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Z3 Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Z3 Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $472k 40k 11.93
2025-12-31 $494k 40k 12.52

More positions owned by Z3 Capital Partners

ClearBridge Energy MLP Fund (EMO)
Palantir Technologies Incorporated Class A Cl A (PLTR)
Bank of America Corporation (BAC)
NVIDIA Corporation (NVDA)
Hancock John Finl Opptys Sh Ben Int Sh Ben Int New (BTO)
Blackrock Science & Technology SHS (BST)
Amazon (AMZN)
Neuberger Next Generation Common Stock (NBXG)
Alphabet Incorporated Cap Stk Class A Cap Stk Cl A (GOOGL)
Pacer Fds Tr Us Large Cap Cash Cows Us Lrg Cp Cash (COWG)
Tesla Motors (TSLA)
Ft Vest Smid Rising Divid Achievers Target Ft Vest Smid (SDVD)
Microsoft Corporation (MSFT)
Blackrock Science & Technology Shs Ben Int Shs Ben Int (BSTZ)
Micron Technology (MU)

View all positions for Z3 Capital Partners

Top funds holding Trevi Therapeutics

NEA Management Company
BlackRock
Frazier Life Sciences Management
FMR
Vanguard Group
Vivo Capital
Vanguard Capital Management
Marshall Wace
Rubric Capital Management
Wellington Management Company
MPM Oncology Impact Management
Viking Global Investors
Alliancebernstein
Geode Capital Management
Eventide Asset Management

View all funds holding Trevi Therapeutics